Solid Dosage
GEA can supply the right technology for Manufacturing Solid Dosage Forms for Gastrointestinal Applications, incl. high-volume production, effervescent processing and MUPS.
Comprising a varied landscape of antacids, antiulcerants, vitamins and minerals, antiemetics, antinauseants, antidiarrheals and anti-obesity products, the gastrointestinal drugs market is segmented into a variety of oral solid dosage forms that require a wide range of different production techniques.
For example, for products that have to act in the stomach, effervescent dosages are often preferred. By contrast, for products that have to act in the intestines, MUPS or coated tablets are more prevalent.
Many of these products have to be produced in high volumes as they represent a large portion of the over-the-counter (OTC) market.
Whatever your application, GEA can supply the right equipment and technology for your production requirements: from integrated granulation lines for high-volume production and single-pot processors adapted to effervescent processing to tablet presses that can handle MUPS or effervescent formulations.
For coating applications, available technologies include fluid bed coating for smaller particles, such as powders, granules, seeds, crystals, pellets and small tablets, a multipurpose processor that uses proven fluid bed technology to achieve granulation, drying and pellet coating (or tablet coating) in a single processor and a continuous tablet coater that accurately deposits controlled amounts of coating materials on tablets, even if they are hygroscopic or friable.
Mostrar 4 de 25
Como integradores de sistemas, unimos nuestro conocimiento sobre la tecnología de procesos y el diseño de plantas a los productos de software de los líderes del mercado.
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
La reducción de residuos es importante para nosotros en GEA, y aprovechando el poder de la tecnología de liofilización, podemos transformar los excedentes de alimentos en productos valiosos y duraderos, ayudando a reducir sus residuos, prolongar la duración de almacenamiento y crear un suministro de alimentos más resistente para las generaciones venideras.
Cuando el productor surcoreano de alimentos de origen vegetal Pulmuone planteó a GEA el reto de desarrollar un giro moderno del tradicional fideo frío masticable (naengmyeon), los expertos en I+D de GEA estuvieron a la altura. Ayudaron a crear lo que ahora es un éxito comercial producido con menos agua y electricidad que los métodos antes existentes. El resultado también es fiel a los orígenes tradicionales del plato, así como a las raíces de salud, bienestar y sostenibilidad de Pulmuone.